The nation of Zimbabwe has rejected a significant American healthcare agreement valued at $367m (272 million pounds) spanning five years over the United States' demand for sensitive information.
The decision came to light after a official document from December was leaked, which showed President Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government spokesperson later clarified that the US was requesting genetic material for research and commercial gain while was unwilling to guarantee the benefits from future treatments.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for more negotiations to secure a deal agreeable to all parties so the nation's critical HIV programme can continue.
Broader Implications
This development follows a comparable case in neighbouring Kenya, where a court blocked a similar health funding agreement after legal challenges were raised about the security of citizens' health data.
After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump claimed its spending was "inefficient" and his administration was pursuing government-to-government agreements to boost openness and accountability.
As per reports, 16 African countries have so far signed these new agreements, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, with no equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Effectively, our country would supply the raw materials for medical research with no assurance that the resulting innovations would be available to our citizens should a new health crisis emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting structures previously set up through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.
"This system is intended to guarantee that when a nation contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to create them."
These objections regarding the US deal "should not be misconstrued as opposition to America," he added.
"We welcome continued discussions with our US partners on how future co-operation could be designed in a manner that honours the independence and dignity of each country."
Medical Community Response
Medical experts expressed it recognised the government's concerns, but recommended that negotiations must proceed since a large portion of the country's HIV programmes relied on international support.
"If specific concerns exist, including those involving data governance or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," it added.
The situation underscores the ongoing tensions between accepting much-needed foreign assistance and protecting national sovereignty in an ever more interconnected world.